p.90 抽出テキスト

jet velocity: an outcome study. Circ Cardiovasc Imaging 2017;10:e006760. https://doi. org/10.1161/CIRCIMAGING.117.006760 485. Adams DH, Popma JJ, Reardon MJ. Transcatheter aortic-valve replacement with a selfexpanding prosthesis. N Engl J Med 2014;371:967–8. https://doi.org/10.1056/ NEJMc1408396 486. Thyregod HGH, Steinbrüchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 2015;65:2184–94. https://doi.org/10.1016/j.jacc.2015.03.014 487. Thourani VH, Suri RM, Gunter RL, Sheng S, O’Brien SM, Ailawadi G, et al. Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients. Ann Thorac Surg 2015;99:55–61. https://doi.org/10.1016/j.athoracsur.2014.06.050 488. Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 2016;387:2218–25. https://doi.org/10.1016/s0140-6736(16)30073-3 489. Coylewright M, Grubb KJ, Arnold SV, Batchelor W, Dhoble A, Horne A Jr, et al. Outcomes of balloon-expandable transcatheter aortic valve replacement in younger patients in the low-risk era. JAMA Cardiol 2025;10:127–35. https://doi.org/10.1001/ jamacardio.2024.4237 490. Ullah W, DiMeglio M, Sana MK, Muhammadzai HZU, Kochar K, Zahid S, et al. Outcomes after transcatheter aortic valve implantation in patients excluded from clinical trials. JACC Adv 2023;2:100271. https://doi.org/10.1016/j.jacadv.2023.100271 491. Reents W, Barth S, Griese DP, Winkler S, Babin-Ebell J, Kerber S, et al. Transfemoral versus transapical transcatheter aortic valve implantation: a single-centre experience. Eur J Cardiothorac Surg 2019;55:744–50. https://doi.org/10.1093/ejcts/ezy363 492. Allen KB, Chhatriwalla AK, Cohen D, Saxon J, Hawa Z, Kennedy KF, et al. Transcarotid versus transapical and transaortic access for transcatheter aortic valve replacement. Ann Thorac Surg 2019;108:715–22. https://doi.org/10.1016/j.athoracsur.2019.02.007 493. Overtchouk P, Folliguet T, Pinaud F, Fouquet O, Pernot M, Bonnet G, et al. Transcarotid approach for transcatheter aortic valve replacement with the Sapien 3 prosthesis. JACC Cardiovasc Interv 2019;12:413–9. https://doi.org/10.1016/j.jcin.2018. 11.014 494. Kumar N, Khera R, Fonarow GC, Bhatt DL. Comparison of outcomes of transfemoral versus transapical approach for transcatheter aortic valve implantation. Am J Cardiol 2018;122:1520–6. https://doi.org/10.1016/j.amjcard.2018.07.025 495. van Wely M, van Nieuwkerk AC, Rooijakkers M, van der Wulp K, Gehlmann H, Verkroost M, et al. Transaxillary versus transfemoral access as default access in TAVI: a propensity matched analysis. Int J Cardiol 2024;394:131353. https://doi.org/ 10.1016/j.ijcard.2023.131353 496. Allen KB, Watson D, Vora AN, Mahoney P, Chhatriwalla AK, Schwartz JG, et al. Transcarotid versus transaxillary access for transcatheter aortic valve replacement with a self-expanding valve: a propensity-matched analysis. JTCVS Tech 2023;21: 45–55. https://doi.org/10.1016/j.xjtc.2023.07.019 497. Salihu A, Ferlay C, Kirsch M, Shah PB, Skali H, Fournier S, et al. Outcomes and safety of transcaval transcatheter aortic valve replacement: a systematic review and meta-analysis. Can J Cardiol 2024;40:2054–62. https://doi.org/10.1016/j.cjca.2024.05. 016 498. Abraham B, Sous M, Sedhom R, Megaly M, Roman S, Sweeney J, et al. Meta-analysis on transcarotid versus transfemoral and other alternate accesses for transcatheter aortic valve implantation. Am J Cardiol 2023;192:196–205. https://doi.org/10.1016/j.amjcard. 2023.01.023 499. Williams MR, Jilaihawi H, Makkar R, O’Neill WW, Guyton R, Malaisrie SC, et al. The PARTNER 3 bicuspid registry for transcatheter aortic valve replacement in low-surgical-risk patients. JACC Cardiovasc Interv 2022;15:523–32. https://doi.org/10. 1016/j.jcin.2022.01.279 500. Waksman R, Craig PE, Torguson R, Asch FM, Weissman G, Ruiz D, et al. Transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis. JACC Cardiovasc Interv 2020;13:1019–27. https://doi.org/10.1016/j.jcin. 2020.02.008 501. Elbadawi A, Saad M, Elgendy IY, Barssoum K, Omer MA, Soliman A, et al. Temporal trends and outcomes of transcatheter versus surgical aortic valve replacement for bicuspid aortic valve stenosis. JACC Cardiovasc Interv 2019;12:1811–22. https://doi.org/ 10.1016/j.jcin.2019.06.037 502. Tchétché D, Ziviello F, De Biase C, De Backer O, Hovasse T, Leroux L, et al. Transcatheter aortic valve implantation with the Evolut platform for bicuspid aortic valve stenosis: the international, multicentre, prospective BIVOLUTX registry. EuroIntervention 2023;19:502–11. https://doi.org/10.4244/eij-d-23-00021 503. Yang L-T, Boler A, Medina-Inojosa Jose R, Scott Christopher G, Maurer Matthew J, Eleid Mackram F, et al. Aortic stenosis progression, cardiac damage, and survival. JACC Cardiovasc Imaging 2021;14:1113–26. https://doi.org/10.1016/j.jcmg.2021.01.017 504. Strange G, Stewart S, Celermajer D, Prior D, Scalia GM, Marwick T, et al. Poor longterm survival in patients with moderate aortic stenosis. J Am Coll Cardiol 2019;74: 1851–63. https://doi.org/10.1016/j.jacc.2019.08.004 505. Samad Z, Vora AN, Dunning A, Schulte PJ, Shaw LK, Al-Enezi F, et al. Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction. Eur Heart J 2016;37:2276–86. https://doi.org/10.1093/eurheartj/ ehv701 506. Oz A, Tsoumas I, Lampropoulos K, Xanthos T, Karpettas N, Papadopoulos D. Cardiac rehabilitation after TAVI—a systematic review and meta-analysis. Curr Probl Cardiol 2023;48:101531. https://doi.org/10.1016/j.cpcardiol.2022.101531 507. Monteagudo Ruiz JM, Galderisi M, Buonauro A, Badano L, Aruta P, Swaans MJ, et al. Overview of mitral regurgitation in Europe: results from the European Registry of mitral regurgitation (EuMiClip). Eur Heart J Cardiovasc Imaging 2018;19:503–7. https://doi. org/10.1093/ehjci/jey011 508. Nalliah CJ, Mahajan R, Elliott AD, Haqqani H, Lau DH, Vohra JK, et al. Mitral valve prolapse and sudden cardiac death: a systematic review and meta-analysis. Heart 2019; 105:144–51. https://doi.org/10.1136/heartjnl-2017-312932 509. Van der Bijl P, Stassen J, Haugaa KH, Essayagh B, Basso C, Thiene G, et al. Mitral annular disjunction in the context of mitral valve prolapse: identifying the at-risk patient. JACC Cardiovasc Imaging 2024;17:1229–45. https://doi.org/10.1016/j.jcmg.2024.03.006 510. Antoine C, Benfari G, Michelena HI, Maalouf JF, Nkomo VT, Thapa P, et al. Clinical outcome of degenerative mitral regurgitation. Circulation 2018;138:1317–26. https://doi. org/10.1161/CIRCULATIONAHA.117.033173 511. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352:875–83. https://doi.org/10.1056/NEJMoa041451 512. O’Gara PT, Grayburn PA, Badhwar V, Afonso LC, Carroll JD, Elmariah S, et al. 2017 ACC Expert Consensus Decision Pathway on the management of mitral regurgitation: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol 2017;70:2421–49. https://doi.org/10.1016/j.jacc. 2017.09.019 513. Dziadzko V, Dziadzko M, Medina-Inojosa JR, Benfari G, Michelena HI, Crestanello JA, et al. Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome. Eur Heart J 2019;40:2194–202. https://doi.org/10.1093/ eurheartj/ehz314 514. Samad Z, Shaw LK, Phelan M, Glower DD, Ersboll M, Toptine JH, et al. Long-term outcomes of mitral regurgitation by type and severity. Am Heart J 2018;203:39–48. https:// doi.org/10.1016/j.ahj.2018.05.001 515. Bakkestrom R, Banke A, Christensen NL, Pecini R, Irmukhamedov A, Andersen M, et al. Hemodynamic characteristics in significant symptomatic and asymptomatic primary mitral valve regurgitation at rest and during exercise. Circ Cardiovasc Imaging 2018;11:e007171. https://doi.org/10.1161/CIRCIMAGING.117.007171 516. Utsunomiya H, Hidaka T, Susawa H, Izumi K, Harada Y, Kinoshita M, et al. Exercise-stress echocardiography and effort intolerance in asymptomatic/minimally symptomatic patients with degenerative mitral regurgitation combined invasivenoninvasive hemodynamic monitoring. Circ Cardiovasc Imaging 2018;11:e007282. https://doi.org/10.1161/CIRCIMAGING.117.007282 517. Butcher SC, Essayagh B, Steyerberg EW, Benfari G, Antoine C, Grigioni F, et al. Factors influencing post-surgical survival in degenerative mitral regurgitation. Eur Heart J 2023; 44:871–81. https://doi.org/10.1093/eurheartj/ehad004 518. Grigioni F, Clavel MA, Vanoverschelde JL, Tribouilloy C, Pizarro R, Huebner M, et al. The MIDA mortality risk score: development and external validation of a prognostic model for early and late death in degenerative mitral regurgitation. Eur Heart J 2018; 39:1281–91. https://doi.org/10.1093/eurheartj/ehx465 519. Del Rio-Pertuz G, Nugent K, Argueta-Sosa E. Right heart catheterization in clinical practice: a review of basic physiology and important issues relevant to interpretation. Am J Cardiovasc Dis 2023;13:122–37. 520. Mentias A, Patel K, Patel H, Gillinov AM, Rodriguez LL, Svensson LG, et al. Prognostic utility of brain natriuretic peptide in asymptomatic patients with significant mitral regurgitation and preserved left ventricular ejection fraction. Am J Cardiol 2016;117: 258–63. https://doi.org/10.1016/j.amjcard.2015.10.040 521. Cawley PJ, Hamilton-Craig C, Owens DS, Krieger EV, Strugnell WE, Mitsumori L, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging 2013;6: 48–57. https://doi.org/10.1161/CIRCIMAGING.112.975623 522. Penicka M, Vecera J, Mirica DC, Kotrc M, Kockova R, Van Camp G. Prognostic implications of magnetic resonance-derived quantification in asymptomatic patients with organic mitral regurgitation: comparison with Doppler echocardiography-derived integrative approach. Circulation 2018;137:1349–60. https://doi.org/10.1161/ CIRCULATIONAHA.117.029332 523. Naoum C, Blanke P, Cavalcante JL, Leipsic J. Cardiac computed tomography and magnetic resonance imaging in the evaluation of mitral and tricuspid valve disease. Circ Cardiovasc Imaging 2017;10:e005331. https://doi.org/10.1161/CIRCIMAGING.116. 005331 524. Kitkungvan D, Nabi F, Kim RJ, Bonow RO, Khan MA, Xu J, et al. Myocardial fibrosis in patients with primary mitral regurgitation with and without prolapse. J Am Coll Cardiol 2018;72:823–34. https://doi.org/10.1016/j.jacc.2018.06.048 Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026